AVITA Medical (RCEL) Research & Development (2018 - 2026)
AVITA Medical's (RCEL) quarterly Research & Development came in at $11.9 million in Q4 2025, up 146.14% YoY from $4.8 million in Q4 2024, and up 218.52% on a QoQ basis from $3.7 million in Q3 2025.
AVITA Medical (RCEL) Research & Development (2018 - 2026) Analysis & Trends
AVITA Medical (RCEL) has 8 years of Research & Development data on file, last reported at $11.9 million in Q4 2025.
- Quarterly Research & Development rose 146.14% year-over-year to $11.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36.3 million (up 2320.55% YoY) and the FY2025 annual result came in at $53.1 million, up 160.99% from the prior year.
- Research & Development rose to $11.9 million in Q4 2025, from $3.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $14.3 million in Q2 2025 to a low of -$13.4 million in Q3 2024.
- A 5-year average of $5.8 million and a median of $5.3 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2021 — Research & Development jumped 246.49% — and 2024, when it plunged 405.69%.
- Tracing RCEL's Research & Development over 5 years: stood at $11.3 million in 2021, then increased by 1.08% to $11.4 million in 2022, then tumbled by 40.84% to $6.8 million in 2023, then slipped by 28.31% to $4.8 million in 2024, then jumped by 146.14% to $11.9 million in 2025.
- The last three Research & Development figures came in at $11.9 million (Q4 2025), $3.7 million (Q3 2025), and $14.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | AVITA Medical | 311.80 Mn | 300.67 Mn | 17.77 Mn | 13.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.57 Mn |
| Dec 31, 2025 | 11.94 Mn |
| Sep 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 14.31 Mn |
| Mar 31, 2025 | 6.28 Mn |
| Dec 31, 2024 | 4.85 Mn |
| Sep 30, 2024 | -13.43 Mn |
| Jun 30, 2024 | 4.89 Mn |
| Mar 31, 2024 | 5.19 Mn |
| Dec 31, 2023 | 6.77 Mn |
| Sep 30, 2023 | 4.39 Mn |
| Jun 30, 2023 | 5.08 Mn |
| Mar 31, 2023 | 6.54 Mn |
| Dec 31, 2022 | 11.44 Mn |
| Sep 30, 2022 | 5.41 Mn |
| Mar 31, 2022 | 4.83 Mn |
| Sep 30, 2021 | 11.31 Mn |
| Jun 30, 2021 | 8.08 Mn |
| Mar 31, 2021 | 3.65 Mn |
| Dec 31, 2020 | 3.36 Mn |